Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	189.95	165.6	174.86	192.04	157.13	183.58	97.38	99.27	141.08	107.95	117.83	112.57	80.62	122.72	175.76	94.31	63.32	122.47	190.18	167.95
Short-Term Investments	278.14	248.48	177.24	115.75	111.21	60.05	126.4	119.49	72.47	98.42	83.26	72.43	106.88	67.89	24.96	43.9	82.25	59.73	10	57.91
Cash & Short-Term Investments	468.09	414.07	352.1	307.78	268.34	243.63	223.78	218.76	213.55	206.37	201.08	184.99	187.49	190.61	200.72	138.21	145.58	182.2	200.18	225.87
Cash Growth	74.44%	69.96%	57.34%	40.70%	25.66%	18.05%	11.29%	18.25%	13.90%	8.27%	0.18%	33.85%	28.79%	4.61%	0.27%	-38.81%	-44.86%	-43.68%	-45.06%	-10.51%
Accounts Receivable	23.22	15.59	51.74	31.91	40.07	41.72	24.89	20.45	16	21.27	3.04	24.65	7.42	12.66	11.16	7.81	29.44	3.99	3.22	2.55
Other Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	7.66	-	-	-	-	-	-
Total Trade Receivables	23.22	15.59	51.74	31.91	40.07	41.72	24.89	20.45	16	21.27	3.04	24.65	7.42	20.32	11.16	7.81	29.44	3.99	3.22	2.55
Inventory	73.14	54.9	41.4	48.18	22.07	26.36	28.68	34.86	27.28	31.12	25.58	23.96	23.43	21.6	14.62	19.92	13.22	3.68	5.61	6.38
Other Current Assets	29.71	42.61	30.29	32.44	25.43	20.08	33.95	26.95	13.77	17.54	26.4	12.44	13.16	10.54	15.31	14.01	10.52	6.59	8.5	10.01
Total Current Assets	594.17	527.18	475.53	420.31	355.91	331.8	311.3	301.02	270.59	276.3	256.11	246.04	231.5	243.06	241.82	179.94	198.76	196.45	217.51	244.81
Net Property, Plant & Equipment	11.32	11.75	11.73	11.38	11.06	11.04	11.66	12.4	13.04	12.67	13.59	14.33	6.62	7.04	8.17	6.22	7.29	8.38	9.3	8.84
Other Intangible Assets	15	15.25	15.5	15.75	16	16.25	16.5	16.75	17	17.25	17.5	17.75	18	18.25	18.5	18.75	19	19.25	19.5	19.75
Other Long-Term Assets	204.79	209.46	209.58	213.71	216.36	221.47	215.84	212.25	219.05	220.11	195.87	206.22	186.74	191.32	191.47	5.67	5.92	8.72	6.55	5.81
Total Assets	825.28	763.63	712.33	661.15	599.33	580.55	555.3	542.43	519.67	526.32	483.06	484.33	442.86	459.67	459.95	210.58	230.97	232.8	252.86	279.21
Accounts Payable	24.4	2.03	6.15	8.96	1.98	2.04	8.33	7.39	5.63	8.25	1.01	0.65	1.39	7.9	1.47	2.52	3.38	1.87	1.65	4.16
Accrued Expenses	108.35	112.04	94.22	88.35	75.9	80.51	69.53	63.32	44.72	44.67	41.15	35.32	20.89	30.11	30.87	34.5	38.89	38.03	28.53	31.06
Current Portion of Leases	3.17	2.99	2.7	2.52	2.29	1.99	2.03	2.09	2.28	2.25	2.31	2.24	3.48	3.3	3.27	3.34	3.31	3.38	3.25	2.64
Unearned Revenue	-	-	-	-	-	-	-	0.01	0.16	0.31	2.56	4.67	6.5	-	12.09	-	-	-	-	-
Other Current Liabilities	20.69	22.13	20.52	18	17.09	16.08	16.07	11.48	11.43	8.19	6.43	4.6	4.33	5.75	8.79	3.19	4.77	1.54	1	0.93
Total Current Liabilities	156.61	139.18	123.59	117.83	97.27	100.62	95.96	84.29	64.21	63.67	53.47	47.47	36.59	47.07	56.49	43.54	50.35	44.82	34.43	38.78
Long-Term Leases	5.86	6.51	7.02	7.24	7.62	7.86	8.56	9.32	9.86	10.01	10.65	11.28	2.13	2.62	3.44	1.28	2.1	2.67	3.5	3.5
Other Long-Term Liabilities	57.13	50.33	46.34	41.07	36.95	33.63	13.77	13.73	13.7	13.81	13.82	13.92	14.05	13.84	16.02	12.26	12.27	0.27	0.89	1.14
Total Long-Term Liabilities	62.98	56.84	53.36	48.32	44.57	41.5	22.34	23.04	23.57	23.82	24.47	25.2	16.18	16.46	19.45	13.54	14.37	2.94	4.38	4.64
Total Liabilities	219.59	196.03	176.95	166.14	141.84	142.12	118.29	107.33	87.78	87.48	77.94	72.68	52.77	63.52	75.95	57.08	64.72	47.76	38.81	43.42
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-in Capital	1,046	1,030	1,012	989.81	970.24	959.72	949.28	934.77	927.58	916.76	908.3	900.96	894.33	888.12	880.55	874.15	866.94	860.48	853.14	844.26
Accumulated Other Comprehensive Income	-0.67	-0.03	-0.16	-0.05	-0.17	-0.16	-0.04	-0.13	-0.05	0.01	-0	0.01	0.06	0.04	-0.07	-0.09	-0.1	-0.07	-0.05	0.03
Retained Earnings	-439.55	-462.14	-476.34	-494.77	-512.6	-521.14	-512.26	-499.56	-495.65	-477.95	-503.19	-489.33	-504.3	-492.03	-496.5	-720.59	-700.61	-675.4	-639.06	-608.52
Shareholders' Equity	605.69	567.61	535.38	495.01	457.49	438.44	437.01	435.1	431.9	438.84	405.13	411.66	390.1	396.15	384.01	153.49	166.24	185.04	214.05	235.79
Total Liabilities & Equity	825.28	763.63	712.33	661.15	599.33	580.55	555.3	542.43	519.67	526.32	483.06	484.33	442.86	459.67	459.95	210.58	230.97	232.8	252.86	279.21
Total Debt	9.03	9.5	9.72	9.77	9.92	9.86	10.6	11.4	12.14	12.26	12.96	13.52	5.62	5.92	6.71	4.61	5.41	6.05	6.75	6.14
Net Cash (Debt)	459.07	404.58	342.38	298.02	258.43	233.77	213.19	207.36	201.41	194.11	188.12	171.47	181.88	184.69	194.02	133.59	140.17	176.15	193.44	219.73
Net Cash Growth	77.64%	73.06%	60.60%	43.72%	28.31%	20.43%	13.32%	20.93%	10.74%	5.10%	-3.04%	28.35%	29.76%	4.85%	0.30%	-39.20%	-45.55%	-44.34%	-46.69%	-12.31%
Net Cash Per Share	5.57	4.96	4.28	3.82	3.39	3.23	2.97	2.92	2.85	2.67	2.68	2.39	2.61	2.59	2.75	1.93	2.03	2.55	2.82	3.21
Book Value	605.69	567.61	535.38	495.01	457.49	438.44	437.01	435.1	431.9	438.84	405.13	411.66	390.1	396.15	384.01	153.49	166.24	185.04	214.05	235.79
Book Value Per Share	7.35	6.96	6.69	6.35	6.01	6.06	6.09	6.13	6.11	6.04	5.77	5.75	5.59	5.55	5.44	2.22	2.40	2.68	3.12	3.45
Tangible Book Value	590.69	552.36	519.88	479.26	441.49	422.19	420.51	418.35	414.9	421.59	387.63	393.91	372.1	377.9	365.51	134.74	147.24	165.79	194.55	216.04
Tangible Book Value Per Share	7.17	6.77	6.50	6.15	5.80	5.84	5.86	5.89	5.87	5.80	5.52	5.50	5.33	5.29	5.18	1.94	2.13	2.40	2.83	3.16

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Apr 28, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error